RegentAtlantic Capital’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.29M | Sell |
41,395
-737
| -2% | -$62.4K | 0.1% | 143 |
|
|
2022
Q2 | $3.51M | Sell |
42,132
-1,170
| -3% | -$96.5K | 0.12% | 136 |
|
|
2022
Q1 | $3.56M | Sell |
43,302
-2,424
| -5% | -$190K | 0.1% | 152 |
|
|
2021
Q4 | $3.42M | Sell |
45,726
-2,474
| -5% | -$186K | 0.1% | 165 |
|
|
2021
Q3 | $3.65M | Sell |
48,200
-3,473
| -7% | -$269K | 0.11% | 148 |
|
|
2021
Q2 | $4M | Sell |
51,673
-3,097
| -6% | -$239K | 0.12% | 129 |
|
|
2021
Q1 | $3.84M | Sell |
54,770
-4,609
| -8% | -$348K | 0.13% | 132 |
|
|
2020
Q4 | $4.21M | Sell |
59,379
-10,433
| -15% | -$655K | 0.17% | 112 |
|
|
2020
Q3 | $4.01M | Sell |
69,812
-18,564
| -21% | -$1.11M | 0.18% | 103 |
|
|
2020
Q2 | $5.38M | Sell |
88,376
-6,595
| -7% | -$407K | 0.3% | 72 |
|
|
2020
Q1 | $5.22M | Buy |
94,971
+43,154
| +83% | +$2.89M | 0.41% | 67 |
|
|
2019
Q4 | $3.74M | Buy |
51,817
+20,518
| +66% | +$1.4M | 0.23% | 112 |
|
|
2019
Q3 | $2.07M | Sell |
31,299
-267
| -0.8% | -$17.2K | 0.14% | 157 |
|
|
2019
Q2 | $1.96M | Sell |
31,566
-639
| -2% | -$36.9K | 0.13% | 163 |
|
|
2019
Q1 | $1.74M | Sell |
32,205
-2,960
| -8% | -$166K | 0.12% | 171 |
|
|
2018
Q4 | $2.06M | Buy |
35,165
+537
| +2% | +$33.7K | 0.17% | 141 |
|
|
2018
Q3 | $2.29M | Sell |
34,628
-635
| -2% | -$42K | 0.18% | 144 |
|
|
2018
Q2 | $2.33M | Sell |
35,263
-1,455
| -4% | -$97.9K | 0.2% | 123 |
|
|
2018
Q1 | $2.45M | Buy |
36,718
+2,590
| +8% | +$174K | 0.2% | 126 |
|
|
2017
Q4 | $2.23M | Buy |
34,128
+1,441
| +4% | +$93.5K | 0.18% | 132 |
|
|
2017
Q3 | $2.1M | Buy |
32,687
+330
| +1% | +$21.3K | 0.18% | 138 |
|
|
2017
Q2 | $2.09M | Sell |
32,357
-115
| -0.4% | -$7.26K | 0.19% | 135 |
|
|
2017
Q1 | $1.98M | Sell |
32,472
-266
| -0.8% | -$16K | 0.18% | 138 |
|
|
2016
Q4 | $1.91M | Sell |
32,738
-75
| -0.2% | -$4.42K | 0.19% | 139 |
|
|
2016
Q3 | $1.9M | Sell |
32,813
-294
| -0.9% | -$17.3K | 0.2% | 132 |
|
|
2016
Q2 | $1.91M | Sell |
33,107
-2,318
| -7% | -$133K | 0.18% | 125 |
|
|
2016
Q1 | $2.14M | Sell |
35,425
-504
| -1% | -$28.2K | 0.24% | 108 |
|
|
2015
Q4 | $1.96M | Sell |
35,929
-1,485
| -4% | -$85.2K | 0.21% | 133 |
|
|
2015
Q3 | $2.13M | Sell |
37,414
-965
| -3% | -$55.2K | 0.2% | 123 |
|
|
2015
Q2 | $2.1M | Sell |
38,379
-1,814
| -5% | -$99.8K | 0.19% | 124 |
|
|
2015
Q1 | $2.19M | Buy |
40,193
+675
| +2% | +$34K | 0.19% | 123 |
|
|
2014
Q4 | $1.84M | Buy |
39,518
+1,591
| +4% | +$74.5K | 0.16% | 134 |
|
|
2014
Q3 | $1.74M | Sell |
37,927
-245
| -0.6% | -$11.5K | 0.16% | 130 |
|
|
2014
Q2 | $1.77M | Sell |
38,172
-2,105
| -5% | -$99.1K | 0.16% | 129 |
|
|
2014
Q1 | $1.87M | Sell |
40,277
-16,960
| -30% | -$741K | 0.18% | 119 |
|
|
2013
Q4 | $2.36M | Sell |
57,237
-2,000
| -3% | -$78.7K | 0.23% | 113 |
|
|
2013
Q3 | $2.17M | Sell |
59,237
-999
| -2% | -$37.8K | 0.24% | 109 |
|
|
2013
Q2 | $2.23M | Buy |
+60,236
| New | +$2.15M | 0.27% | 106 |
|
Other funds holding DOX
BGC
CI
RegentAtlantic Capital's DOX Position: Q3 2022 in Review
RegentAtlantic Capital reduced its Amdocs (DOX) stake by 1.7% in Q3 2022, selling an estimated $62.4K and leaving 41,395 shares worth $3.29M. The position accounts for 0.1% of the portfolio, ranked #143.
RegentAtlantic Capital first reported a position in DOX in Q2 2013 and has held it in 38 quarters since. The position peaked at $5.38M in Q2 2020. 450 funds tracked by Wall St. Rank hold DOX as of Q3 2022.
- RegentAtlantic Capital held 41,395 shares of Amdocs worth $3.29M as of Q3 2022.
- RegentAtlantic Capital sold 737 Amdocs shares in Q3 2022, an estimated $62.4K.
- Amdocs made up 0.1% of RegentAtlantic Capital's portfolio in Q3 2022, its #143 holding.
- RegentAtlantic Capital first reported a position in Amdocs in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Amdocs position peaked at $5.38M in Q2 2020.
- 450 funds tracked by Wall St. Rank held Amdocs as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.